A Phase II, Randomized, Open-label, Multi-center Study of AK104 in Combination With Lenvatinib Versus Lenvatinib in Patients With Advanced Hepatocellular Carcinoma Who Have Progressed on Atezolizumab and Bevacizumab
Latest Information Update: 28 May 2025
At a glance
- Drugs Cadonilimab (Primary) ; Lenvatinib
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Akeso Biopharma
Most Recent Events
- 28 May 2025 New trial record